Developing and evaluating comprehensive HIV infection control strategies: issues and challenges
- PMID: 20397937
- PMCID: PMC2913596
- DOI: 10.1086/651480
Developing and evaluating comprehensive HIV infection control strategies: issues and challenges
Abstract
As described elsewhere in this supplement, development of effective methods for prevention of human immunodeficiency virus (HIV) infection has proven to be more challenging than development of effective treatment for the disease. New strategies to control the HIV epidemic are urgently needed; this urgency creates interest in investigation of the possibility of using antiretroviral treatment in combination with other modalities to control the epidemic. This article summarizes current knowledge concerning prevention modalities in the context of the drivers of the HIV epidemic in specific communities, describes challenges in investigating test-and-treat strategies, and proposes research directions for addressing these challenges to investigate the impact of prevention strategies on mitigation of epidemics.
Conflict of interest statement
References
-
- PEPFAR. Prevention with positives. 2009. Oct 9, http://www.pepfar.gov/documents/organization/114393.pdf.
-
- Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–656. - PubMed
-
- Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–666. - PubMed
-
- Dao H, Mofenson LM, Ekpini R, et al. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol. 2007;197:S42–S55. - PubMed
Publication types
MeSH terms
Grants and funding
- R21 AI077304/AI/NIAID NIH HHS/United States
- UM1 AI069432/AI/NIAID NIH HHS/United States
- AI36214/AI/NIAID NIH HHS/United States
- NS051132/NS/NINDS NIH HHS/United States
- MH083552/MH/NIMH NIH HHS/United States
- R37 AI051164/AI/NIAID NIH HHS/United States
- MH62512/MH/NIMH NIH HHS/United States
- R01 MH083552/MH/NIMH NIH HHS/United States
- R01 AI051164/AI/NIAID NIH HHS/United States
- R24 AI106039/AI/NIAID NIH HHS/United States
- R01 NS051132/NS/NINDS NIH HHS/United States
- AI074621/AI/NIAID NIH HHS/United States
- U01 AI069432/AI/NIAID NIH HHS/United States
- AI74621/AI/NIAID NIH HHS/United States
- P30 MH062512/MH/NIMH NIH HHS/United States
- P01 DA012065/DA/NIDA NIH HHS/United States
- AI-51164-01/AI/NIAID NIH HHS/United States
- P30 AI036214/AI/NIAID NIH HHS/United States
- AI077304/AI/NIAID NIH HHS/United States
- DA012065/DA/NIDA NIH HHS/United States
- AI69432/AI/NIAID NIH HHS/United States
- P01 AI074621/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
